Loading clinical trials...
Loading clinical trials...
ctHPVDNA Adapted ChemoRadiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer (CHART-AC)
Conditions
Interventions
HPV ctDNA Response based radiation
Chemotherapy
+1 more
Locations
2
United States
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
Start Date
March 1, 2026
Primary Completion Date
January 1, 2029
Completion Date
January 1, 2029
Last Updated
February 20, 2026
NCT06157151
NCT07192055
NCT05307939
NCT04094454
NCT05639972
NCT06640283
Lead Sponsor
Jennifer Dorth
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions